Animal Venoms as Potential Source of Anticonvulsants

Animal Venoms as Potential Source of... | F1000Research "use strict";function _typeof(t){return(_typeof="function"==typeof Symbol&&"symbol"==typeof Symbol.iterator?function(t){return typeof t}:function(t){return t&&"function"==typeof Symbol&&t.constructor===Symbol&&t!==Symbol.prototype?"symbol":typeof t})(t)}!function(){var t=function(){var t,e,o=[],n=window,r=n;for(;r;){try{if(r.frames.__tcfapiLocator){t=r;break}}catch(t){}if(r===n.top)break;r=r.parent}t||(!function t(){var e=n.document,o=!!n.frames.__tcfapiLocator;if(!o)if(e.body){var r=e.createElement("iframe");r.style.cssText="display:none",r.name="__tcfapiLocator",e.body.appendChild(r)}else setTimeout(t,5);return!o}(),n.__tcfapi=function(){for(var t=arguments.length,n=new Array(t),r=0;r 3&&2===parseInt(n[1],10)&&"boolean"==typeof n[3]&&(e=n[3],"function"==typeof n[2]&&n[2]("set",!0)):"ping"===n[0]?"function"==typeof n[2]&&n[2]({gdprApplies:e,cmpLoaded:!1,cmpStatus:"stub"}):o.push(n)},n.addEventListener("message",(function(t){var e="string"==typeof t.data,o={};if(e)try{o=JSON.parse(t.data)}catch(t){}else o=t.data;var n="object"===_typeof(o)&&null!==o?o.__tcfapiCall:null;n&&window.__tcfapi(n.command,n.version,(function(o,r){var a={__tcfapiReturn:{returnValue:o,success:r,callId:n.callId}};t&&t.source&&t.source.postMessage&&t.source.postMessage(e?JSON.stringify(a):a,"*")}),n.parameter)}),!1))};"undefined"!=typeof module?module.exports=t:t()}(); dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}}; ;NREUM.loader_config={accountID:"438030",trustKey:"438030",agentID:"772317073",licenseKey:"97f8f67f26",applicationID:"772317073"} ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"97f8f67f26",applicationID:"772317073",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;fn,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})(); window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://f1000research.com/js/vendor/ckeditor/' window.reactTheme = 'research'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is "complete" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event "completion" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', "PixelInitialized", {}); (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:2318163,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv='); search file_upload Submit your research search menu close search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Open Data, Software and Code Guidelines Open Data and Accessible Source Materials Guidelines (HSS) Open Data, Software and Code Guidelines (PSE) Prepublication Checks Production Process Posters and Slides Guidelines Document Guidelines Article Processing Charges Peer Review Finding Article Reviewers About How it Works For Reviewers Our Advisors Policies Glossary FAQs For Developers Newsroom Contact My Research Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { "@context": "https://schema.org", "@type": "ScholarlyArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://f1000research.com/articles/13-225" }, "headline": "Animal Venoms as Potential Source of Anticonvulsants", "datePublished": "2024-03-27T12:06:47", "dateModified": "2024-03-27T12:06:47", "author": [ { "@type": "Person", "name": "Syafiq Asnawi Zainal Abidin" }, { "@type": "Person", "name": "Anthony Kin Yip Liew" }, { "@type": "Person", "name": "Iekhsan Othman" }, { "@type": "Person", "name": "Farooq Shaikh" } ], "publisher": { "@type": "Organization", "name": "F1000Research", "logo": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 480, "width": 60 } }, "image": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 1200, "width": 150 }, "description": "Abstract* Epilepsy affects millions of people worldwide, and there is an urgent need to develop safe and effective therapeutic agents. Animal venoms contain diverse bioactive compounds like proteins, peptides, and small molecules, which may possess medicinal properties against epilepsy. In recent years, research has shown that venoms from various organisms such as spiders, ants, bees, wasps, and conus snails have anticonvulsant and antiepileptic effects by targeting specific receptors and ion channels. This review underscores the significance of purified proteins and toxins from these sources as potential therapeutic agents for epilepsy. In conclusion, this review emphasizes the valuable role of animal venoms as a natural resource for further exploration in epilepsy treatment research." } { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": "1", "item": { "@id": "https://f1000research.com/", "name": "Home" } }, { "@type": "ListItem", "position": "2", "item": { "@id": "https://f1000research.com/browse/articles", "name": "Browse" } }, { "@type": "ListItem", "position": "3", "item": { "@id": "https://f1000research.com/articles/13-225/v1", "name": "Animal Venoms as Potential Source of Anticonvulsants" } } ] } Home Browse Animal Venoms as Potential Source of Anticonvulsants ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article Zainal Abidin SA, Liew AKY, Othman I and Shaikh F. Animal Venoms as Potential Source of Anticonvulsants [version 1; peer review: 3 approved] . F1000Research 2024, 13 :225 ( https://doi.org/10.12688/f1000research.147027.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Review Animal Venoms as Potential Source of Anticonvulsants [version 1; peer review: 3 approved] Syafiq Asnawi Zainal Abidin https://orcid.org/0000-0002-8249-7668 1 , Anthony Kin Yip Liew 1 , Iekhsan Othman 1 , Farooq Shaikh 2 Syafiq Asnawi Zainal Abidin https://orcid.org/0000-0002-8249-7668 1 , Anthony Kin Yip Liew 1 , Iekhsan Othman 1 , Farooq Shaikh 2 PUBLISHED 27 Mar 2024 Author details Author details 1 Monash University Malaysia, Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Bandar Sunway, Selangor, 47500, Malaysia 2 School of Dentistry and Medical Sciences, Charles Sturt University, Orange, New South Wales, 2800, Australia Syafiq Asnawi Zainal Abidin Roles: Conceptualization, Formal Analysis, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Anthony Kin Yip Liew Roles: Conceptualization, Formal Analysis, Investigation, Methodology, Validation, Writing – Review & Editing Iekhsan Othman Roles: Validation, Writing – Review & Editing Farooq Shaikh Roles: Methodology, Validation, Visualization, Writing – Review & Editing OPEN PEER REVIEW DETAILS REVIEWER STATUS Abstract Abstract* Epilepsy affects millions of people worldwide, and there is an urgent need to develop safe and effective therapeutic agents. Animal venoms contain diverse bioactive compounds like proteins, peptides, and small molecules, which may possess medicinal properties against epilepsy. In recent years, research has shown that venoms from various organisms such as spiders, ants, bees, wasps, and conus snails have anticonvulsant and antiepileptic effects by targeting specific receptors and ion channels. This review underscores the significance of purified proteins and toxins from these sources as potential therapeutic agents for epilepsy. In conclusion, this review emphasizes the valuable role of animal venoms as a natural resource for further exploration in epilepsy treatment research. READ ALL READ LESS Keywords Epilepsy, Anticonvulsant, Animal Venom, Bioactive Compounds, GABA, NMDA Corresponding Author(s) Syafiq Asnawi Zainal Abidin ( [email protected] ) Close Corresponding author: Syafiq Asnawi Zainal Abidin Competing interests: No competing interests were disclosed. Grant information: Monash University Malaysia Global Asia in the 21st-Century (GA21) Platform Seed Grant, GA-HW-18-S01 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Copyright: © 2024 Zainal Abidin SA et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: Zainal Abidin SA, Liew AKY, Othman I and Shaikh F. Animal Venoms as Potential Source of Anticonvulsants [version 1; peer review: 3 approved] . F1000Research 2024, 13 :225 ( https://doi.org/10.12688/f1000research.147027.1 ) First published: 27 Mar 2024, 13 :225 ( https://doi.org/10.12688/f1000research.147027.1 ) Latest published: 27 Mar 2024, 13 :225 ( https://doi.org/10.12688/f1000research.147027.1 ) 1. Introduction Epilepsy is a global epidemic that affects more than 50 million people worldwide, making it one of the most common neurological diseases. 1 Almost 80% of epileptic patients come from low- and middle-income countries. 1 The Task Force of the International League Against Epilepsy (ILAE) defined epileptic seizure as a transient occurrence of symptoms caused by abnormally excessive brain neuronal activity. Epilepsy is a brain disorder prone to epileptic seizures and consequences from cognitive, neurobiological, psychological, and social aspects. 2 There are several types of epileptic seizures, depending on the symptoms. One-third of the epileptic seizures occurred as generalized seizures, whereas two-thirds began as focal seizures. Generalized seizures can be classified into six groups: tonic-clonic, myoclonic, atonic, tonic, clonic, and absence seizures. 3 All these symptoms happen without warning and involve loss of consciousness on the patient. Tonic seizures are characterized by constant muscle contraction, while tremors in the limbs indicate clonic seizures. Tonic-clonic seizures have symptoms that combined both tonic and clonic seizures symptoms. The contraction of limb muscles is followed by limb extension and tremors with back arching for around ten to thirty seconds. Epileptogenesis is the gradual development of epilepsy in a normal brain. 4 The causes of epilepsy can be identified as structural or genetics. Structural causes of epilepsy include brain tumors, brain trauma, and other neurodegenerative diseases. Brain areas prone to trauma causing epileptogenesis include structures of the temporal lobe such as the amygdala, hippocampus, and piriform cortex. 5 Brain electrical activity is usually non-synchronous in normal humans, while patients suffering from epileptic seizures will have excessive synchronized firing of neuronal firing, which causes a paroxysmal depolarizing shift. Neuronal biochemical receptors play an essential role in epileptogenesis, primarily glutamate receptors (ionotropic and metabotropic). When the receptors are activated, Ca2+ ions will increase within the area of the cells. Therefore, glutamate is seen as one of the most critical molecules in epileptogenesis as it causes excitotoxicity, i.e., neurons are severely depolarised. 4 Epilepsy treatment may include drugs, surgery, and even diet changes. The standard first-line therapy for patients newly diagnosed with epilepsy is usually by antiepileptic drugs (AEDs) such as phenobarbital, phenytoin, carbamazepine, or valproic acid. Second line medications such as oxcarbazepine, gabapentin, topiramate, felbamate, and lamotrigine are also applied in the treatment. 6 No single AED is proved to be more effective than another, with all drugs producing some side effects depending on the individual treated. These drugs used have a 70% to 80% success rate in treating epilepsy, while the remaining 20% to 30% still suffer from seizures or more significant adverse effects. 7 Since epilepsy is caused by the malfunction of ion channels, Gamma-aminobutyric acid (GABA)-ergic neuron inhibition, and excess glutamate release, most AED will target these specific pathways. 8 Drugs that target ion channels include carbamazepine, oxcarbazepine, phenytoin, and lamotrigine, which block sodium channels. 9 Gabapentin binds on volt-age-dependent calcium channel proteins in rat models and is believed to have GABAergic effects. GABA-mediated inhibition is vital as the binding of GABA to their receptors leads to an influx of negatively charged chloride ions (Cl-) which in turn causes cell hyperpolarisation. Barbiturates and benzodiazepines treat epilepsy by targeting the GABAergic transmission and increasing chloride ion influx. 10 Glutamate, which is a primary excitatory neurotransmitter were also believed to play a part in epilepto-genesis. Application of antagonists to the glutamate receptor such as N-methyl-D-aspartate (NMDA) demonstrated anticonvulsant effects in animal models. Valproate, felbamate, and topiramate are NMDA receptor antagonists which are currently used. However, these drugs are known to present several undesirable side effects. 8 2. Animal venom as a potential source of anticonvulsants The earth’s flora and fauna are an important reservoir of naturally derived therapeutic agents. Since ancient times, humans have utilized these resources to treat diseases and improving wellbeing. One significant source is the venom and toxins from venomous and poisonous animals. The venom consists of proteins, enzymes, inorganic ions, and nucleotides, which can induce a plethora of effects, including necrosis, coagulation, haemorrhagic, and neurotoxicity depending on the type of venom. 11 Targeted sites of venom are specific and diverse due to the different constitutions and may target receptors and channels such as neuro-junctions and ion channels. 12 Animal venom has been regarded as an essential source of potential therapeutic agents in human diseases such as neurodegenerative diseases, cardiovascular diseases, autoimmune diseases, and cancer. 13 – 16 In this literature review, the different types of venom used in treating epilepsy is discussed. 2.1 Spider venom ( Table 1 ) Neuroprotective potential of various venom fractions and components from venomous spider species has been identified ( Table 1 ). Arylamine-enriched fraction isolated from the venom of funnel-web grass spider Agelenopsis aperta demonstrated significant anticonvulsant properties by antagonizing and blocking NMDA receptor and dihydropyridine (DHP) calcium channels. 17 Overexcitation of NMDA receptors and DHP calcium channels were found to be responsible for the pathophysiology of epilepsy. 18 , 19 In the study by Jackson and Parks, 17 arylamine-enriched venom fraction was administered both intravenously (i.v.) on male Sprague-Dawley rats induced with epilepsy using kainic acid (KA), picrotoxin (PIC), and bicuculline (BIC). Subjects administered with KA when paired with the venom fractions demonstrated less to nonconvulsive behavior until 70 minutes. Symptoms of seizures subsided after 4 hours with no deaths observed in the 10 subjects. Subjects administered with BIC and PIC paired with the venom fraction (i.v.) also shows closely similar observations and seem mildly sedated at the same time responsive to external stimuli. Table 1. Anticonvulsive proteins/peptides from spider venom and the mechanism of action. Species Venom Component Mechanism Reference Spiders Agelenopsis aperta AG2 NMDA receptor antagonists/blocks dihydropyridine (DHP) sensitive calcium channels 17 Parawixia bistrata Parawixin 2/FrPBAII Blocks GABAergic transporters, interferes GABA uptake 24 , 27 Parawixia bistrata Parawixin 10 Increases glutamate uptake 25 Scaptocosa rapto-ria SrTx1 Blocks GABAergic transporters, interferes GABA uptake 23 Parawixia bistriata Peptide fraction (RT10) In-vitro neuroprotective effect against excitotoxicity 26 Active fraction (PbTx1.2.3) from Brazillian orb-weaver spiders Parawixia bistrata demonstrated potential anticonvulsive activity in synaptosomes model from rat cerebral cortex. 20 Glutamate and gamma-Amnobutyric acid (GABA) uptake balance is crucial in maintaining normal brain function. Functioning as the primary excitatory neurotransmitter in the brain, the increase of glutamate activity is critical in epileptogenesis. 21 In contrast, GABA counterbalances neuronal excitation by acting as the primary inhibitory neurotransmitter. Hence, changes to GABA balance in the brain may trigger seizures. 22 PbTx1.2.3 was demonstrated to increase glutamate uptake while inhibiting GABA uptake in cortical synaptosomes in a dose-dependent manner. Drugs that stimulate GABA concentration are potent anticonvulsants such as vigabatrin and tiagabine. 22 Moreover, PbTx1.2.3 successfully protected neurons in the rat retinal glaucoma model from excitotoxic death. 20 Therefore, PbTx1.2.3 may serve as a template for potential anticonvulsant and neuroprotection drug development. FrPbAII is another compound found in P. bistrata venom, which was studied for anticonvulsive and anxiolytic properties. Bicuculline was injected into Area-tempestas of male Wistar rats to induce seizures and treated with FrPbAII. The toxin component significantly inhibited seizures elicited by bicuculline. In addition, FrPbAII was demonstrated to block GABAergic transporters that caused epilepsy. 23 Animal behavior study using male Wistar rats also showed anticonvulsive properties of FrPbAII. Rats were induced with seizures using pentylenetetrazol and were treated with diazepam, nipecotic acid, and FrPbAII. All subjects treated with diazepam, nipecotic acid, and FrPbAII showed anticonvulsive properties with reduced immobility, increased exploratory walking, rearing, and head-dips than saline control pentylenetetrazole (PTZ)-induced seizure subjects. 24 Parawixin-10 is another polyamine found in P. bistrata venom which elicits anticonvulsive properties. Parawixin-10 was administered via i.c.v. injection using a cannula and kainic acid (KA), NMDA, and PTZ to induce seizures. Parawixin-10 demonstrated anticonvulsive properties with the lowest dose required for KA compared to NMDA and PTZ indicating that the mode of action for Parawixin-10 is through the inhibition of excitatory transmission of non-NMDA receptors. Neurochemistry data from the study also showed an increase in L-glutamate and glycine uptake, wherein elevated levels of both compounds are responsible for epilepsy. However, the important mode of action for Parawixin-10 has yet to be pinpointed and thus requires further investigation and studies. 25 Additional study on P. bistrata venom fraction, RT10, which comprised of Parawixins 1 and 2, demonstrated neuroprotective effects on neuron-glia primary culture against high L-glutamate concentrations. 26 2.2 Scorpion venom Several subtypes of α and β neurotoxins have been described from the venom of Asian scorpion Buthus martensi Karsch (BmK) ( Table 2 ). These neurotoxins were found to modulate voltage-gated sodium channels (VGSCs). 28 , 29 Antinociceptive effects from BmK venom were demonstrated by the activity of BmK I (α-like neurotoxin) and BmK IT2 (β-like neurotoxins). 30 , 31 A study by Zhao , et al. 32 in PTZ and pilocarpine-induced epilepsy rats showed significant anticonvulsant activity from the administration of BmK IT2. The effects of BmK IT2 were attributed to its ability to modulate sodium channels in the hippocampus. A further study with a different toxin from BmK, Bmk-AS, demonstrated similar antiepileptic activities in PTZ and pilocarpine-induced epilepsy in the rat model. 33 In another study, a novel peptide synthesised and derived from the Malaysian forest scorpion venom, Hetermetrus spinifer , was shown to reduce inflammation in PTZ-induced epilepsy in-vivo. 34 The 25 amino acid peptide named HsTx2 alleviate epilepsy progression by targeting the circ_0001293/miR-8114/TGF- β2 axis, which is responsible for inflammation response in astrocytes. 34 Table 2. Anticonvulsive proteins/peptides from scorpion venom and the mechanism of action. Species Venom Component Mechanism Reference Scorpions Buthus martensi Karsch BmK IT2 Interferes with voltage gated sodium ion channels 32 Buthus martensi Karsch Bmk AS Interferes with voltage gated sodium ion channels 33 Heterometrus spinifer HsTx2 Regulation of inflammatory responses through the circ_0001293/miR-8114/TGF-β2 axis 34 2.3 Bee and Wasp venom Bee and wasp venom is rich in compounds that act on various biological systems, especially in the nervous system. These compounds include peptides, amines, enzymes, and amino acids ( Table 3 ). 35 Both peptides and acyl polyamines have been studied to treat many neurology-related diseases. A single study on mellitin, a major component of the venom from Apis mellifera (honey bee), demonstrated anticonvulsant effects in bicuculine-induced seizures in rats. 36 Mellitin could potentially induced its neuroprotective activities via activation of phospholipase A 2 and consequently modulating the GABAergic and glutamergic systems. 36 Denatured crude venom from Polybia occidentalis (Yellow-banded Polybia wasp) identified dose-dependent effectiveness in treating KA-induced seizures rat model. This finding suggests that venom-induced anticonvulsive activities by antagonizing NMDA-glu receptors. Additional results include in-vivo anticonvulsive effects in rats with PIC- and BIC-induced seizures. 37 Recent study on a venom peptide isolated from Polybia occidentalis , occidentalin-1202, pinpointed anti-seizure effects by blocking glutamate and kainic acid interaction with the kainite receptor. 38 A different study on the venom of Polybia ignobilis (Brazilian social wasp) demonstrated a similar outcome by preventing seizures induced by KA, PIC, and BIC. 39 Table 3. Anticonvulsive proteins/peptides from wasp and bee venom and the mechanism of action. Species Venom Component Mechanism Reference Wasps Polybia occidnetalis Denatured crude venom NMDA receptor antagonists/increases glutamate uptake 37 Polybia ignobilis Denatured crude venom Interferes with glutamate and GABA receptors 39 Polybia paulista Peptide fractions GABA receptors and calcium ion channel interference 40 Agelaia vicina Crude boiled venom Interferes with GABA and glutamate uptake 42 Philanthus triangulum F. β-PTx/δ-PTx Inhibits glutamate uptake 43 Polybia paulista Ppnp7/Neuropolybin Neuroprotective effects against tonic-clonic seizures in PTZ-induced rats 41 Polybia occidentalis Occidentalin-1202 Inhibit glutamate uptake through blockage of kainate receptors 45 Chartergellus communis Chartergellus-CP1 Postulated to block calcium channels 44 Bees Apis meliffera Melittin Increases GABA transmission, modulation of glutamatergic neurotransmission 36 Low molecular weight fractions of the venom from Polybia paulista (Neotropical social wasp) exhibited anticonvulsant activities in 60% of animals (Wistar rats) induced with PTZ. 40 Compared with diazepam treatment, both offer protection from seizures, but the venom demonstrated fewer sedation effects. 40 Additionally, peptides isolated from Polybia paulista , Ppnp7 and neuropolybin, demonstrated tonic-clonic seizure protection in 80% of PTZ-induced rats. 41 Agelaia vicina venom showed inhibition of GABA and glutamate uptake responsible during epileptogenesis. The venom targeted enzymes accountable for the regulation of ion flow, thus disrupting ion concentration gradient. Additionally, free amino acids were found to inhibit GABA and glutamate uptake. 42 Philanthus triangulum F. wasp venom contains components such as β-PTX and δ-PTX, which show effects on animal glutamatergic neuro-junctions. These components were found to inhibit the uptake of glutamate in the neuromuscular synapse on locusts. A study showed a significant decrease in glutamate uptake on hippocampal slices of rats incubated with δ-PTX (74% decrease) and a less significant reduction with incubation in β-PTX (18%). Based on the findings, the venom from Philanthus triangulum F. wasps demonstrated potentials as a source of anticonvulsant agents due to its interference with glutamate uptake, a critical factor in epileptogenesis. 43 Besides PTZ-induced seizures, a treatment using wasp venom peptide from Chartegellus communis (Social wasp), Chartergellus-CP1, showed neuroprotective effects in pilocarpine-induced epilepsy. 44 In the study, electroencephalographic abnormalities that are associated with pilocarpine-induced seizures were significantly reduced upon administration of Charthergellus-CP1. 44 2.4 Ant venom Ant venom contains an arsenal of molecules that ranges from proteins, peptides, free amino acids, alkaloids, formic acid, and several other organic molecules. 46 Like other venomous organisms, the venom has been a subject of interest to uncover its properties and therapeutic potential, including as an anticonvulsive agent ( Table 4 ). The venom of Dinoponera quadriceps (South American giant ant) has been studied for anticonvulsant effects. An initial study by Noga , et al. 47 demonstrated the pro-and anticonvulsant effects of the crude venom in-vivo. Injection of crude venom (DqTX) in the lateral ventricle region of mice brain showed procursive behavior and tonic-clonic seizures. Table 4. Anticonvulsive protein/peptides from ant venom and the mechanism of action. Species Venom Component Mechanism Reference Ants Dinoponera quadriceps Crude venom DqV GABA receptor interference 48 Dinoponera quadriceps DqTx 1 – DqTx 6 GABA receptor interference 49 Dinoponera quadriceps M-PONTX-Dq3a, M-PONTX-Dq3b and M-PONTX-Dq3c Decreased production of reactive oxygen and nitrogen species 38 Interestingly, the effects were negated via pre-administration of the same but denatured venom (AbDq), hence, protected the animals against seizures and death. 47 Similar results were noted in another study by Lopes , et al. 48 Different administration routes of D. quadriceps venom in mice seizure models were responsible for neuroprotective or neurotoxic effects. Intraperitoneal administration of the venom demonstrated increased latency to seizure with an increased survival rate in the PTZ-induced seizure model. In contrast, endovascular treatment-induced neurotoxic effects by reducing the seizure latency time. In another study utilising PTZ-induced seizure model, three different peptides from Dinoponera quadriceps (M-PONTX-Dq3a, M-PONTX-Dq3b, and M-PONTX, Dq3c) also showed anticonvulsant properties by reducing neuroinflammation caused by reactive oxygen species. 38 In a subsequent study by Noga , et al., 49 the anticonvulsant effects from the fractions of D. quadriceps crude venom were investigated. The crude venom was fractionated using high-performance liquid chromatography (HPLC) and yielded six fractions labelled DqTX1 – DqTX6. The fractions were administered intracerebroventricularly in BIC-induced seizure rats, and the anticonvulsant effects were determined. DqTX-6 showed significant neuroprotection with 62.5% protection from seizures and 100% protection from death. Since BIC induces seizures by interfering with GABA receptors, the mode of action for the DqTX-6 fraction is most likely to be GABAergic. 49 2.5 Conus snail venom Conopeptides from the venom of marine cone snails belonging to the genus Conus have been identified with potentials as antinociceptive, antiepileptic, neuroprotective, and cardioprotective agents. 50 There are at least four peptide families with neuroprotective and cardioprotective activities from Conus snail venom, namely, conantokins, omega-conotoxin (ω-Conotoxin), mu-conotoxin (μ-Conotoxin), and kappa-conotoxin (κ-Conotoxin) ( Table 5 ). 51 Conantokins are of particular interest due to their potential in treating epilepsy. Seven types of conantokin peptides were identified, and all were described as NMDA receptor antagonists. 52 Table 5. Anticonvulsive proteins/peptides from cone snail venom and the mechanism of action. Species Venom Component Mechanism Reference Cone snails Conus geographus Con-G NMDA receptor blocker 57 Conus lynceus Con-L NMDA receptor blocker 59 Conus radiatus Con-R NMDA receptor blocker 58 Conus magus Ziconotide NMDA receptor blocker, N-type calcium channel blocker 60 Conantokin-G (Con-G) is a well-studied conantokin from the venom of Geography cone snail Conus geographus. It was advanced into clinical trial phase 1 to treat intractable epilepsy and potential neuro-protectant in ischemic stroke. 53 The peptide demonstrated significant antiepileptic activities in animal models of epilepsy, such as maximal electroshock, PTZ induced, and Frings audiogenic seizures. 54 – 56 Anticonvulsive mode of Con-G was via the dose-dependent inhibition of NMDA responses. 57 Besides Con-G, Conantokin-R (Con-R) from Conus radiatus Conantokin-L (Con-L) from Conus lynceus showed significant anticonvulsant effects when administered intracerebroventricularly to subjects induced with Frings audiogenic seizures. 58 , 59 Ziconotide, a synthetic derivative of ω-Conotoxin from Conus magus , demonstrated anticonvulsant and anxiolytic effects by potentially reducing extracellular concentrations of glutamate via N-type calcium channel inhibition. 60 3. Future directions The potential of venom as a source of anticonvulsants warrants further exploration and investigation, extending beyond its current focus to encompass other venomous animals which could potentially include snakes. Snake venom is a complex mixture of proteins, peptides, and small molecules that serve as a defence mechanism and aid digestion for snakes towards their prey. Despite its toxicity, snake venom can be an essential source of therapeutic compounds, as demonstrated by its potential in treating cardiovascular disease and as an anti-microbial, anti-viral, anti-fungal, and anti-cancer agent. 61 To date, there is only a few studies the anticonvulsant potential of snake venom via Ophiophagus hannah (king cobra) and Micrurus mipartus (Costa Rican coral snake). Saha , et al. 62 isolated a non-protein toxin called KC-MMTx from O. hannah crude venom and demonstrated its neuroprotective activity in animal models of epilepsy. KC-MMTx presented significant protection against seizures induced by strychnine, PTZ, and yohimbine, and its potential in interfering with the GABAergic and glycine receptors was touted. Remarkably, toxins from Costa Rican coral snake (MmTX1 and MmTX2) were found to specifically target GABA receptors and significantly improve its sensitivity via allosteric binding. 63 Moreover, the ability of snake venom toxins, particularly three-finger toxins (3FTXs), to bind with nicotinic acetylcholine receptors (nAChR) presents another promising avenue in this field. This is noteworthy because the overactivation of nAChR is frequently associated with tonic-clonic convulsions and epilepsy in mammals. 64 – 67 In addition to snake venoms, venoms from sea anemone could also be another important source of therapeutic proteins and peptides as anticonvulsants. 68 Several sea anemone toxins extracted from Stichodactyla heliantus , Actinia equina , Anemonia eryhtrae , Anemonia sulcata , Bunodosoma caissarum, Bunodosoma granulifera and Heteractis magnifica were found to selectively target Kv1 channels. 69 These findings hold particular importance as Kv1 ion channels play a clinically relevant role in the pathogenesis of neurological diseases, including epilepsy. 70 4. Conclusions Epilepsy remains one of the most critical health burdens in the world. However, the disease currently presents a significant challenge in discovering and developing therapeutic agents that are safe and effective. Venom-based therapeutics has been a subject of focus due to their potential to combat various disorders such as cardiovascular diseases and cancer. This present review demonstrates that animal venom could exert anticonvulsant effects by targeting and regulating specific receptors, modulating uptakes of molecules such as glutamate and glycine, and antagonizing ion channels. In addition, the advancement of proteomic and genomic technology has presented us with the ability to characterize and purify proteins with therapeutic potentials accurately. More proteins/compounds can be isolated and tested in-vivo for anticonvulsant activities. Animal venom represents a promising avenue for researchers to further explore and investigate its compounds as a source of potential antiepileptic/anticonvulsive agents. Data availability No data are associated with this article. Acknowledgements The authors would like to acknowledge the Monash University Malaysia, Proteomics and Metabolomics Platform and the Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS), Monash University Malaysia for research facilities and publication support. References 1. Disease, G.B.DInjury, IPrevalence, C: Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388 : 1545–1602. PubMed Abstract | Publisher Full Text | Free Full Text 2. Fisher RS, Acevedo C, Arzimanoglou A, et al. : ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014; 55 : 475–482. PubMed Abstract | Publisher Full Text 3. Manford M: Recent advances in epilepsy. J. Neurol. 2017; 264 : 1811–1824. PubMed Abstract | Publisher Full Text | Free Full Text 4. McNamara JO, Huang YZ, Leonard AS: Molecular Signaling Mechanisms Underlying Epileptogenesis. Sci. STKE. 2006; 2006 : re12–re12. Publisher Full Text 5. Aroniadou-Anderjaska V, Fritsch B, Qashu F, et al. : Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy. Epilepsy Res. 2008; 78 : 102–116. PubMed Abstract | Publisher Full Text | Free Full Text 6. Angalakuditi M, Angalakuditi N: A comprehensive review of the literature on epilepsy in selected countries in emerging markets. Neuropsychiatr. Dis. Treat. 2011; 7 : 585–597. PubMed Abstract | Publisher Full Text | Free Full Text 7. French JA, Kanner AM, Bautista J, et al. : Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004; 62 : 1261–1273. PubMed Abstract | Publisher Full Text 8. Nakken K, Heuser K, Alfstad K, et al. : Hvordan virker antiepileptika. Tidsskr. Nor. Laegeforen. 2014; 134 : 42–46. PubMed Abstract | Publisher Full Text 9. Farber N, Jiang X, Heinkel C, et al. : Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity. Mol. Psychiatry. 2002; 7 : 726–733. PubMed Abstract | Publisher Full Text 10. Sutton KG, Martin DJ, Pinnock RD, et al. : Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurons. Br. J. Pharmacol. 2002; 135 : 257–265. PubMed Abstract | Publisher Full Text | Free Full Text 11. Fry BG, Roelants K, Champagne DE, et al. : The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms. Annu. Rev. Genomics Hum. Genet. 2009; 10 : 483–511. PubMed Abstract | Publisher Full Text 12. Gawade SP: Snake venom neurotoxins: Pharmacological classification. J. Toxicol..: Toxin. Rev. 2004; 23 : 37–96. Publisher Full Text 13. Chen N, Xu S, Zhang Y, et al. : Animal protein toxins: origins and therapeutic applications. Biophys. Rep. 2018; 4 : 233–242. Publisher Full Text 14. Zainal Abidin SA, Lee YQ, Othman I, et al. : Malaysian Cobra Venom: A Potential Source of Anti-Cancer Therapeutic Agents. Toxins (Basel). 2019; 11 . PubMed Abstract | Publisher Full Text | Free Full Text 15. Brunner HR, Gavras H, Waeber B, et al. : Clinical use of an orally acting converting enzyme inhibitor: captopril. Hypertension. 1980; 2 : 558–566. PubMed Abstract | Publisher Full Text 16. Ye M, Chung H-S, Lee C, et al. : Neuroprotective effects of bee venom phospholipase A 2 in the 3xTg AD mouse model of Alzheimer’s disease. J. Neuroinflammation. 2016; 13 : 10. PubMed Abstract | Publisher Full Text | Free Full Text 17. Jackson H, Parks TN: Anticonvulsant action of an arylamine-containing fraction from Agelenopsis spider venom. Brain Res. 1990; 526 : 338–341. PubMed Abstract | Publisher Full Text 18. Kapur J: Role of NMDA receptors in the pathophysiology and treatment of status epilepticus. Epilepsia open. 2018; 3 : 165–168. PubMed Abstract | Publisher Full Text | Free Full Text 19. Ullal GR: Dihydropyridine group of calcium channel antagonist in epilepsy. Indian J. Physiol. Pharmacol. 1994; 38 : 43–46. PubMed Abstract 20. Fontana ACK, Guizzo R, Beleboni RO, et al. : Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake. Br. J. Pharmacol. 2003; 139 : 1297–1309. PubMed Abstract | Publisher Full Text | Free Full Text 21. Meldrum BS: The role of glutamate in epilepsy and other CNS disorders. Neurology. 1994; 44 : S14–S23. PubMed Abstract 22. Treiman DM: GABAergic mechanisms in epilepsy. Epilepsia. 2001; 42 : 8–12. Publisher Full Text 23. Cairrão M, Ribeiro AM, Pizzo AB, et al. : Anticonvulsant and GABA uptake inhibition properties of venom fractions from the spiders Parawixia bistriata and Scaptocosa raptoria. Pharm. Biol. 2002; 40 : 472–477. Publisher Full Text 24. Liberato JL, Cunha AO, Mortari MR, et al. : Anticonvulsant and anxiolytic activity of FrPbAII, a novel GABA uptake inhibitor isolated from the venom of the social spider Parawixia bistriata (Araneidae: Araneae). Brain Res. 2006; 1124 : 19–27. PubMed Abstract | Publisher Full Text 25. Fachim HA, Cunha AO, Pereira AC, et al. : Neurobiological activity of Parawixin 10, a novel anticonvulsant compound isolated from Parawixia bistriata spider venom (Araneidae: Araneae). Epilepsy Behav. 2011; 22 : 158–164. PubMed Abstract | Publisher Full Text 26. Primini EO, Liberato JL, Fontana ACK, et al. : Neuroprotective properties of RT10, a fraction isolated from Parawixia bistriata spider venom, against excitotoxicity injury in neuron-glia cultures. J. Venom. Anim. Toxins Incl. Trop. Dis. 2019; 25 . Publisher Full Text 27. Godoy LD, Liberato JL, Celani MVB, et al. : Disease Modifying Effects of the Spider Toxin Parawixin2 in the Experimental Epilepsy Model. Toxins (Basel). 2017; 9 . PubMed Abstract | Publisher Full Text | Free Full Text 28. Goudet C, Chi C-W, Tytgat J: An overview of toxins and genes from the venom of the Asian scorpion Buthus martensi Karsch. Toxicon. 2002; 40 : 1239–1258. PubMed Abstract | Publisher Full Text 29. Zuo X-P, Ji Y-H: Molecular mechanism of scorpion neurotoxins acting on sodium channels. Mol. Neurobiol. 2004; 30 : 265–278. PubMed Abstract | Publisher Full Text 30. Chen J, Tan Z-Y, Zhao R, et al. : The modulation effects of BmK I, an α-like scorpion neurotoxin, on voltage-gated Na+ currents in rat dorsal root ganglion neurons. Neurosci. Lett. 2005; 390 : 66–71. PubMed Abstract | Publisher Full Text 31. Zhang XY, Bai ZT, Chai ZF, et al. : Suppressive effects of BmK IT2 on nociceptive behavior and c-Fos expression in spinal cord induced by formalin. J. Neurosci. Res. 2003; 74 : 167–173. PubMed Abstract | Publisher Full Text 32. Zhao R, Zhang XY, Yang J, et al. : Anticonvulsant effect of BmK IT2, a sodium channel-specific neurotoxin, in rat models of epilepsy. Br. J. Pharmacol. 2008; 154 : 1116–1124. PubMed Abstract | Publisher Full Text | Free Full Text 33. Zhao R, Weng CC, Feng Q, et al. : Anticonvulsant activity of BmK AS, a sodium channel site 4-specific modulator. Epilepsy Behav. 2011; 20 : 267–276. PubMed Abstract | Publisher Full Text 34. Hu Y, Meng B, Yin S, et al. : Scorpion venom peptide HsTx2 suppressed PTZ-induced seizures in mice via the circ_0001293/miR-8114/TGF-β2 axis. J. Neuroinflammation. 2022; 19 : 284. PubMed Abstract | Publisher Full Text | Free Full Text 35. de OBR, Pizzo AB, Fontana AC, et al. : Spider and wasp neurotoxins: pharmacological and biochemical aspects. Eur. J. Pharmacol. 2004; 493 : 1–17. PubMed Abstract | Publisher Full Text 36. Soares-Silva B, Beserra-Filho JIA, Morera PMA, et al. : The bee venom active compound melittin protects against bicuculline-induced seizures and hippocampal astrocyte activation in rats. Neuropeptides. 2022; 91 : 102209. PubMed Abstract | Publisher Full Text 37. Mortari MR, Cunha AOS, De Oliveira L, et al. : Anticonvulsant and behavioural effects of the denatured venom of the social wasp Polybia occidentalis (Polistinae, Vespidae). Basic Clin. Pharmacol. Toxicol. 2005; 97 : 289–295. PubMed Abstract | Publisher Full Text 38. Paes LCF, Lima DB, Silva DMA, et al. : Exploring the neuroprotective potential of antimicrobial peptides from Dinoponera quadriceps venom against pentylenetetrazole-induced seizures in vivo. Toxicon. 2024; 237 : 107538. PubMed Abstract | Publisher Full Text 39. Cunha AO, Mortari MR, Oliveira L, et al. : Anticonvulsant effects of the wasp Polybia ignobilis venom on chemically induced seizures and action on GABA and glutamate receptors. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2005; 141 : 50–57. Publisher Full Text 40. do Couto LL , Dos Anjos LC, Araujo MAF, et al. : Anticonvulsant and anxiolytic activity of the peptide fraction isolated from the venom of the social wasp Polybia paulista. Pharmacogn. Mag. 2012; 8 : 292–299. PubMed Abstract | Publisher Full Text | Free Full Text 41. de Castro e Silva J , Lopes do Couto L, de Oliveira Amaral H , et al. : Neuropolybin: A new antiseizure peptide obtained from wasp venom. Biochem. Pharmacol. 2020; 181 : 114119. PubMed Abstract | Publisher Full Text 42. Pizzo AB, Fontana AC, Coutinho-Netto J, et al. : Effects of the crude venom of the social wasp Agelaia vicina on gamma-aminobutyric acid and glutamate uptake in synaptosomes from rat cerebral cortex. J. Biochem. Mol. Toxicol. 2000; 14 : 88–94. PubMed Abstract | <a target="xrefwindow" id="d18406e2136" href="https://doi.org/10.1002/(sici)1099-0461(2000)14:2 Publisher Full Text 43. van Marle J , Piek T, Lind A, et al. : Reduction of high affinity glutamate uptake in rat hippocampus by two polyamine-like toxins isolated from the venom of the predatory wasp Philanthus triangulum F. Experientia. 1986; 42 : 157–158. PubMed Abstract | Publisher Full Text 44. Lopes KS, Quintanilha MVT, de Souza ACB , et al. : Antiseizure potential of peptides from the venom of social wasp Chartergellus communis against chemically-induced seizures. Toxicon. 2021; 194 : 23–36. PubMed Abstract | Publisher Full Text 45. Mortari MR, Cunha AOS, dos Anjos LC , et al. : A new class of peptides from wasp venom: a pathway to antiepileptic/neuroprotective drugs. Brain Commun. 2023; 5 : fcad016. PubMed Abstract | Publisher Full Text | Free Full Text 46. Touchard A, Aili SR, Fox EGP, et al. : The Biochemical Toxin Arsenal from Ant Venoms. Toxins. 2016; 8 : 30. Publisher Full Text 47. Noga DA, Cagni FC, Santos JR, et al. : Pro- and Anticonvulsant Effects of the Ant Dinoponera quadriceps (Kempf) Venom in Mice. Neotrop. Entomol. 2015; 44 : 410–417. PubMed Abstract | Publisher Full Text 48. Lopes KS, Rios ER, Lima CN, et al. : The effects of the Brazilian ant Dinoponera quadriceps venom on chemically induced seizure models. Neurochem. Int. 2013; 63 : 141–145. PubMed Abstract | Publisher Full Text 49. Noga DA, Brandao LE, Cagni FC, et al. : Anticonvulsant Effects of Fractions Isolated from Dinoponera quadriceps (Kempt) Ant Venom (Formicidae: Ponerinae). Toxins (Basel). 2016; 9 : 9. PubMed Abstract | Publisher Full Text | Free Full Text 50. Han TS, Teichert RW, Olivera BM, et al. : Conus venoms - a rich source of peptide-based therapeutics. Curr. Pharm. Des. 2008; 14 : 2462–2479. PubMed Abstract | Publisher Full Text 51. Twede VD, Miljanich G, Olivera BM, et al. : Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads. Curr. Opin. Drug Discov. Devel. 2009; 12 : 231–239. PubMed Abstract 52. Olivera BM, Cruz LJ, De Santos V, et al. : Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry. 1987; 26 : 2086–2090. PubMed Abstract | Publisher Full Text 53. Malmberg AB, Gilbert H, McCabe RT, et al. : Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and T. Pain. 2003; 101 : 109–116. Publisher Full Text 54. Williams AJ, Dave JR, Phillips JB, et al. : Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies. J. Pharmacol. Exp. Ther. 2000; 294 : 378–386. PubMed Abstract 55. Lu XC, Williams AJ, Wagstaff JD, et al. : Effects of delayed intrathecal infusion of an NMDA receptor antagonist on ischemic injury and peri-infarct depolarizations. Brain Res. 2005; 1056 : 200–208. PubMed Abstract | Publisher Full Text 56. Williams AJ, Ling G, Berti R, et al. : Treatment with the snail peptide CGX-1007 reduces DNA damage and alters gene expression of c-fos and bcl-2 following focal ischemic brain injury in rats. Exp. Brain Res. 2003; 153 : 16–26. PubMed Abstract | Publisher Full Text 57. Donevan SD, McCabe RT: Conantokin G Is an NR2B-Selective Competitive Antagonist of N-Methyl-d-aspartate Receptors. Mol. Pharmacol. 2000; 58 : 614–623. PubMed Abstract | Publisher Full Text 58. White HS, McCabe RT, Armstrong H, et al. : In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus. J. Pharmacol. Exp. Ther. 2000; 292 : 425–432. PubMed Abstract 59. Jimenez EC, Donevan S, Walker C, et al. : Conantokin-L, a new NMDA receptor antagonist: determinants for anticonvulsant potency. Epilepsy Res. 2002; 51 : 73–80. PubMed Abstract | Publisher Full Text 60. Zamani M, Budde T, Bozorgi H: Intracerebroventricular administration of N-type calcium channel blocker ziconotide displays anticonvulsant, anxiolytic, and sedative effects in rats: A preclinical and pilot study. Epilepsy Behav. 2020; 111 : 107251. PubMed Abstract | Publisher Full Text 61. Zainal Abidin SA, Lee YQ, Othman I, et al. : Malaysian Cobra Venom: A Potential Source of Anti-Cancer Therapeutic Agents. Toxins. 2019; 11 : 75. PubMed Abstract | Publisher Full Text | Free Full Text 62. Saha A, Gomes A, Chakravarty AK, et al. : CNS and anticonvulsant activity of a non-protein toxin (KC-MMTx) isolated from King Cobra ( Ophiophagus hannah ) venom. Toxicon. 2006; 47 : 296–303. Publisher Full Text 63. Rosso JP, Schwarz JR, Diaz-Bustamante M, et al. : MmTX1 and MmTX2 from coral snake venom potently modulate GABAA receptor activity. Proc. Natl. Acad. Sci. USA. 2015; 112 : E891–E900. PubMed Abstract | Publisher Full Text | Free Full Text 64. Nirthanan S, Awal W, Niranjan NR: Snake a-Neurotoxins and the Nicotinic Acetylcholine Receptor. Snake Venoms. 2017; 215 . Publisher Full Text 65. Dixit KS, Dhasmana KM, Saxena RC, et al. : Antagonism of intracerebrally induced nicotinic convulsions in mice: A method for measuring the central antinicotinic activity of CNS acting agents. Psychopharmacologia. 1971; 19 : 67–72. Publisher Full Text 66. Becchetti A, Grandi LC, Cerina M, et al. : Nicotinic acetylcholine receptors and epilepsy. Pharmacol. Res. 2023; 189 : 106698. PubMed Abstract | Publisher Full Text 67. Son L, Kryukova E, Ziganshin R, et al. : Novel Three-Finger Neurotoxins from Naja melanoleuca Cobra Venom Interact with GABAA and Nicotinic Acetylcholine Receptors. Toxins. 2021; 13 : 164. PubMed Abstract | Publisher Full Text | Free Full Text 68. Madio B, King GF, Undheim EAB: Sea Anemone Toxins: A Structural Overview. Mar. Drugs. 2019; 17 . PubMed Abstract | Publisher Full Text | Free Full Text 69. Finol-Urdaneta RK, Belovanovic A, Micic-Vicovac M, et al. : Marine Toxins Targeting Kv1 Channels: Pharmacological Tools and Therapeutic Scaffolds. Mar. Drugs. 2020; 18 : 173. PubMed Abstract | Publisher Full Text | Free Full Text 70. Allen NM, Weckhuysen S, Gorman K, et al. : Genetic potassium channel-associated epilepsies: Clinical review of the K(v) family. Eur. J. Paediatr. Neurol. 2020; 24 : 105–116. PubMed Abstract | Publisher Full Text Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 27 Mar 2024 ADD YOUR COMMENT Comment Author details Author details 1 Monash University Malaysia, Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Bandar Sunway, Selangor, 47500, Malaysia 2 School of Dentistry and Medical Sciences, Charles Sturt University, Orange, New South Wales, 2800, Australia Syafiq Asnawi Zainal Abidin Roles: Conceptualization, Formal Analysis, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Anthony Kin Yip Liew Roles: Conceptualization, Formal Analysis, Investigation, Methodology, Validation, Writing – Review & Editing Iekhsan Othman Roles: Validation, Writing – Review & Editing Farooq Shaikh Roles: Methodology, Validation, Visualization, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information Monash University Malaysia Global Asia in the 21st-Century (GA21) Platform Seed Grant, GA-HW-18-S01 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Article Versions (1) version 1 Published: 27 Mar 2024, 13:225 https://doi.org/10.12688/f1000research.147027.1 Copyright © 2024 Zainal Abidin SA et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics Views Downloads F1000Research - - PubMed Central info_outline Data from PMC are received and updated monthly. - - Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article Zainal Abidin SA, Liew AKY, Othman I and Shaikh F. Animal Venoms as Potential Source of Anticonvulsants [version 1; peer review: 3 approved] . F1000Research 2024, 13 :225 ( https://doi.org/10.12688/f1000research.147027.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: ? Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Version 1 VERSION 1 PUBLISHED 27 Mar 2024 Views 0 Cite How to cite this report: Cao Z. Reviewer Report For: Animal Venoms as Potential Source of Anticonvulsants [version 1; peer review: 3 approved] . F1000Research 2024, 13 :225 ( https://doi.org/10.5256/f1000research.161164.r293545 ) The direct URL for this report is: https://f1000research.com/articles/13-225/v1#referee-response-293545 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 08 Jul 2024 Zhijian Cao , Wuhan University, Wuhan, Hubei, China Approved VIEWS 0 https://doi.org/10.5256/f1000research.161164.r293545 This is a short review about Animal Venoms as Potential Source of Anticonvulsants written by Syafiq Asnawi Zainal Abidin, Anthony Kin Yip Liew, Iekhsan Othman, and Farooq Shaikh. Epilepsy is a global epidemic that affects more than 50 million people ... Continue reading READ ALL This is a short review about Animal Venoms as Potential Source of Anticonvulsants written by Syafiq Asnawi Zainal Abidin, Anthony Kin Yip Liew, Iekhsan Othman, and Farooq Shaikh. Epilepsy is a global epidemic that affects more than 50 million people worldwide, making it one of the most common neurological diseases. Epilepsy remains one of the most critical health burdens in the world. The discovery of anti-epilepsy agents with high effect and low toxicity is still the most urgent need today and future. Animal venom is confirmed to be one significant and potential source of natural drugs including anticonvulsants. Overall, the theme of this review is very meaningful and interesting. Moreover, the structure and organization of this review is logically clear. From a scientific perspective, the article reviews and summarizes all anti-epileptic peptides and components derived from animal venom sources. Moreover, the direction and focus of future attention and research have also been proposed. All in all, I recommend that this review could be considered to be accepted after a revision. However, some minor questions still need to be modified. Minor points The authors should summarize and provide the molecular characteristics of the animal venom-derived anti-epileptic peptides (such as PbTx1.2.3, FrPbAII, BmK I, BmK IT2, Ppnp7, neuropolybin, Chartergellus-CP1, M-PONTX-Dq3a, M-PONTX-Dq3b, and M-PONTX, Dq3c, and so on), for example the primary amino acid sequences, cysteine pairs, molecular weights, and so on. The language of this review is good. However, there are still some errors in the following. “synthesised” should be adjusted to “synthesized”; “in-vivo” should be adjusted to the italicized “in-vivo”; “mice brain” should be adjusted to “mouse brain”; “mice seizure models” should be adjusted to “mouse seizure models”. Is the topic of the review discussed comprehensively in the context of the current literature? Yes Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes Competing Interests: No competing interests were disclosed. Reviewer Expertise: Animal venom peptides I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Cao Z. Reviewer Report For: Animal Venoms as Potential Source of Anticonvulsants [version 1; peer review: 3 approved] . F1000Research 2024, 13 :225 ( https://doi.org/10.5256/f1000research.161164.r293545 ) The direct URL for this report is: https://f1000research.com/articles/13-225/v1#referee-response-293545 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Ukwubile CA. Reviewer Report For: Animal Venoms as Potential Source of Anticonvulsants [version 1; peer review: 3 approved] . F1000Research 2024, 13 :225 ( https://doi.org/10.5256/f1000research.161164.r293539 ) The direct URL for this report is: https://f1000research.com/articles/13-225/v1#referee-response-293539 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 24 Jun 2024 Cletus Anes Ukwubile , University of Maiduguri, Maiduguri, Borno, Nigeria Approved VIEWS 0 https://doi.org/10.5256/f1000research.161164.r293539 The author has rightly included in the review most essential parameters. This review draws the attention of the audience on the potentials of venom as anticonvulsant agent. The language use was concise and interesting. However, there is the need ... Continue reading READ ALL The author has rightly included in the review most essential parameters. This review draws the attention of the audience on the potentials of venom as anticonvulsant agent. The language use was concise and interesting. However, there is the need to provide scientific names to some of the organisms that serve as venom sources. The use of only common names are scientifically incomplete. The author should also be specific in the conclusion. For instance more proteins/compounds can be..... Proteins are compounds. It should be More compounds be... Is the topic of the review discussed comprehensively in the context of the current literature? Yes Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes Competing Interests: No competing interests were disclosed. Reviewer Expertise: Ethnopharmacology, Pharmacognosy and Natural Products Research. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Ukwubile CA. Reviewer Report For: Animal Venoms as Potential Source of Anticonvulsants [version 1; peer review: 3 approved] . F1000Research 2024, 13 :225 ( https://doi.org/10.5256/f1000research.161164.r293539 ) The direct URL for this report is: https://f1000research.com/articles/13-225/v1#referee-response-293539 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Offor BC. Reviewer Report For: Animal Venoms as Potential Source of Anticonvulsants [version 1; peer review: 3 approved] . F1000Research 2024, 13 :225 ( https://doi.org/10.5256/f1000research.161164.r276839 ) The direct URL for this report is: https://f1000research.com/articles/13-225/v1#referee-response-276839 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 17 May 2024 Benedict C Offor , University of Johannesburg, Auckland Park, Johannesburg, South Africa Approved VIEWS 0 https://doi.org/10.5256/f1000research.161164.r276839 A review entitled Animal venoms as a potential source of anticonvulsants by Zainal Abidin and colleagues is very exciting and informative. Considering the challenges and stereotypes associated with the sufferers of epilepsy, there is a need to explore natural sources ... Continue reading READ ALL A review entitled Animal venoms as a potential source of anticonvulsants by Zainal Abidin and colleagues is very exciting and informative. Considering the challenges and stereotypes associated with the sufferers of epilepsy, there is a need to explore natural sources including venom from organisms for potential therapeutic solutions. The authors demonstrated that venom components from selected venomous organisms interact with receptors, channels, and transporters and induce anticonvulsant activities. Furthermore, venom components could stimulate GABA concentration, and modulation of L-glutamate and glycine uptake by interfering with NMDA and GABAergic transporter making them possible anticonvulsant agents. It would have been more interesting if the authors had presented a Figure summarising possible mechanisms of action of these venom toxins in inducing anticonvulsant activities. Thus, proposing the interactions of these venom toxins with receptors, channels, transporters and downstream responses to the perturbation. The review will be beneficial to both researchers in the field of venomics, pharmacology, physicians, and ordinary people. However, there are some changes I would suggest to improve the manuscript. Abstract Add scorpion venom in the abstract since there is a sub-heading (2.2) about it and highlights about the roles in voltage-gated sodium ion channels, as a potent anticonvulsant agent. Introduction Page 3, Paragraph 1: Reference to back up the definition of epilepsy by the Task Force of the International League Against Epilepsy (ILAE). Page 3, Paragraph 2: Ca2+, 2+ should be in superscript Page 3, Paragraph 3: The first sentence could be supported with reference especially “diet changes as methods to treat epilepsy” Page 3, Paragraph 3: Cl-, - should be in superscript Page 3, Paragraph 5: I would suggest venom and venom toxins with potential effects against epilepsy since there were no approved venom-based drugs available to treat epilepsy. Section 2.1 sub-heading: I suggest removing (Table 1) Page 4, Paragraph 1: If “Subjects” was used to refer to “rats”, I suggest using the latter throughout Page 4, Paragraph 2: “A’ of Aminobutyric should be written with lowercase font Table 2: Voltage-gated? Table 3: Could be moved to sub-section 2.3. Page 5, Paragraph 1: in vivo? Page 5, Paragraph last: Apis mellifera should be in italics The authors’ “Future directions” to explore the venoms of snakes and sea anemones is interesting, considering the role of neurotoxins (three-finger toxins) in snakebite envenoming victims. The interaction of this toxin at the neuromuscular junction inhibits presynaptic voltage-gated calcium channels by so doing causes paralysis of the snakebite victims. Is the topic of the review discussed comprehensively in the context of the current literature? Yes Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes Competing Interests: No competing interests were disclosed. Reviewer Expertise: Venomics I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Offor BC. Reviewer Report For: Animal Venoms as Potential Source of Anticonvulsants [version 1; peer review: 3 approved] . F1000Research 2024, 13 :225 ( https://doi.org/10.5256/f1000research.161164.r276839 ) The direct URL for this report is: https://f1000research.com/articles/13-225/v1#referee-response-276839 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 27 Mar 2024 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Reviewer Reports Invited Reviewers 1 2 3 Version 1 27 Mar 24 read read read Benedict C Offor , University of Johannesburg, Auckland Park, Johannesburg, South Africa Cletus Anes Ukwubile , University of Maiduguri, Maiduguri, Nigeria Zhijian Cao , Wuhan University, Wuhan, China Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert Browse by related subjects keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Cao Z. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 08 Jul 2024 | for Version 1 Zhijian Cao , Wuhan University, Wuhan, Hubei, China 0 Views copyright © 2024 Cao Z. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions This is a short review about Animal Venoms as Potential Source of Anticonvulsants written by Syafiq Asnawi Zainal Abidin, Anthony Kin Yip Liew, Iekhsan Othman, and Farooq Shaikh. Epilepsy is a global epidemic that affects more than 50 million people worldwide, making it one of the most common neurological diseases. Epilepsy remains one of the most critical health burdens in the world. The discovery of anti-epilepsy agents with high effect and low toxicity is still the most urgent need today and future. Animal venom is confirmed to be one significant and potential source of natural drugs including anticonvulsants. Overall, the theme of this review is very meaningful and interesting. Moreover, the structure and organization of this review is logically clear. From a scientific perspective, the article reviews and summarizes all anti-epileptic peptides and components derived from animal venom sources. Moreover, the direction and focus of future attention and research have also been proposed. All in all, I recommend that this review could be considered to be accepted after a revision. However, some minor questions still need to be modified. Minor points The authors should summarize and provide the molecular characteristics of the animal venom-derived anti-epileptic peptides (such as PbTx1.2.3, FrPbAII, BmK I, BmK IT2, Ppnp7, neuropolybin, Chartergellus-CP1, M-PONTX-Dq3a, M-PONTX-Dq3b, and M-PONTX, Dq3c, and so on), for example the primary amino acid sequences, cysteine pairs, molecular weights, and so on. The language of this review is good. However, there are still some errors in the following. “synthesised” should be adjusted to “synthesized”; “in-vivo” should be adjusted to the italicized “in-vivo”; “mice brain” should be adjusted to “mouse brain”; “mice seizure models” should be adjusted to “mouse seizure models”. Is the topic of the review discussed comprehensively in the context of the current literature? Yes Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes Competing Interests No competing interests were disclosed. Reviewer Expertise Animal venom peptides I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Cao Z. Peer Review Report For: Animal Venoms as Potential Source of Anticonvulsants [version 1; peer review: 3 approved] . F1000Research 2024, 13 :225 ( https://doi.org/10.5256/f1000research.161164.r293545) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-225/v1#referee-response-293545 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Ukwubile C. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 24 Jun 2024 | for Version 1 Cletus Anes Ukwubile , University of Maiduguri, Maiduguri, Borno, Nigeria 0 Views copyright © 2024 Ukwubile C. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The author has rightly included in the review most essential parameters. This review draws the attention of the audience on the potentials of venom as anticonvulsant agent. The language use was concise and interesting. However, there is the need to provide scientific names to some of the organisms that serve as venom sources. The use of only common names are scientifically incomplete. The author should also be specific in the conclusion. For instance more proteins/compounds can be..... Proteins are compounds. It should be More compounds be... Is the topic of the review discussed comprehensively in the context of the current literature? Yes Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes Competing Interests No competing interests were disclosed. Reviewer Expertise Ethnopharmacology, Pharmacognosy and Natural Products Research. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Ukwubile CA. Peer Review Report For: Animal Venoms as Potential Source of Anticonvulsants [version 1; peer review: 3 approved] . F1000Research 2024, 13 :225 ( https://doi.org/10.5256/f1000research.161164.r293539) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-225/v1#referee-response-293539 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Offor B. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 17 May 2024 | for Version 1 Benedict C Offor , University of Johannesburg, Auckland Park, Johannesburg, South Africa 0 Views copyright © 2024 Offor B. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions A review entitled Animal venoms as a potential source of anticonvulsants by Zainal Abidin and colleagues is very exciting and informative. Considering the challenges and stereotypes associated with the sufferers of epilepsy, there is a need to explore natural sources including venom from organisms for potential therapeutic solutions. The authors demonstrated that venom components from selected venomous organisms interact with receptors, channels, and transporters and induce anticonvulsant activities. Furthermore, venom components could stimulate GABA concentration, and modulation of L-glutamate and glycine uptake by interfering with NMDA and GABAergic transporter making them possible anticonvulsant agents. It would have been more interesting if the authors had presented a Figure summarising possible mechanisms of action of these venom toxins in inducing anticonvulsant activities. Thus, proposing the interactions of these venom toxins with receptors, channels, transporters and downstream responses to the perturbation. The review will be beneficial to both researchers in the field of venomics, pharmacology, physicians, and ordinary people. However, there are some changes I would suggest to improve the manuscript. Abstract Add scorpion venom in the abstract since there is a sub-heading (2.2) about it and highlights about the roles in voltage-gated sodium ion channels, as a potent anticonvulsant agent. Introduction Page 3, Paragraph 1: Reference to back up the definition of epilepsy by the Task Force of the International League Against Epilepsy (ILAE). Page 3, Paragraph 2: Ca2+, 2+ should be in superscript Page 3, Paragraph 3: The first sentence could be supported with reference especially “diet changes as methods to treat epilepsy” Page 3, Paragraph 3: Cl-, - should be in superscript Page 3, Paragraph 5: I would suggest venom and venom toxins with potential effects against epilepsy since there were no approved venom-based drugs available to treat epilepsy. Section 2.1 sub-heading: I suggest removing (Table 1) Page 4, Paragraph 1: If “Subjects” was used to refer to “rats”, I suggest using the latter throughout Page 4, Paragraph 2: “A’ of Aminobutyric should be written with lowercase font Table 2: Voltage-gated? Table 3: Could be moved to sub-section 2.3. Page 5, Paragraph 1: in vivo? Page 5, Paragraph last: Apis mellifera should be in italics The authors’ “Future directions” to explore the venoms of snakes and sea anemones is interesting, considering the role of neurotoxins (three-finger toxins) in snakebite envenoming victims. The interaction of this toxin at the neuromuscular junction inhibits presynaptic voltage-gated calcium channels by so doing causes paralysis of the snakebite victims. Is the topic of the review discussed comprehensively in the context of the current literature? Yes Are all factual statements correct and adequately supported by citations? Yes Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes Competing Interests No competing interests were disclosed. Reviewer Expertise Venomics I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Offor BC. Peer Review Report For: Animal Venoms as Potential Source of Anticonvulsants [version 1; peer review: 3 approved] . F1000Research 2024, 13 :225 ( https://doi.org/10.5256/f1000research.161164.r276839) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-225/v1#referee-response-276839 Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with F1000Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = "Animal Venoms as Potential Source of Anticonvulsants".replace("'", ''); var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/13-225/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by '); var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/13-225/v1&title=" + encodeURIComponent(lTitle); var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/13-225/v1" + "&title=" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('Zainal Abidin SA et al.'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_custom : [ { name: "LinkedIn", url: linkedInUrl, icon:"/img/icon/at_linkedin.svg" }, { name: "Mendeley", url: "http://www.mendeley.com/import/?url=https://f1000research.com/articles/13-225/v1/mendeley", icon:"/img/icon/at_mendeley.svg" }, { name: "Reddit", url: redditUrl, icon:"/img/icon/at_reddit.svg" }, ] }; var addthis_share = { url: "https://f1000research.com/articles/13-225", templates : { twitter : "Animal Venoms as Potential Source of Anticonvulsants. Zainal Abidin SA et al., published by " + "@F1000Research" + ", https://f1000research.com/articles/13-225/v1" } }; if (typeof(addthis) != "undefined"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter); $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url); $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url); $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url); $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(".addthis_button_expanded").each(function(){ var count = $(this).text(); if (count !== "" && count != "0") $(this).removeClass("is-hidden"); else $(this).addClass("is-hidden"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get("/articles/acj/147027/161164") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay("articles", "article", "161164"); $(document).ready(function() { $( "#frame1" ).on('load', function() { var mydiv = $(this).contents().find("div"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"), titleLivingFigure = tooltipLivingFigure.attr("title"); tooltipLivingFigure.simpletip({ fixed: true, position: ["-115", "30"], baseClass: 'small-tooltip', content:titleLivingFigure + " " }); tooltipLivingFigure.removeAttr("title"); $("body").on("click", ".cite-living-figure", function(e) { e.preventDefault(); var ref = $(this).attr("data-ref"); $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200); }); $("body").on("click", ".close-cite-living-figure", function(e) { e.preventDefault(); $(this).closest(".popup-window-wrapper").fadeOut(200); }); $(document).on("mouseup", function(e) { var metricsContainer = $(".article-metrics-popover-wrapper"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(".article-metrics-close-button").click(); } }); var articleId = $('#articleId').val(); if($("#main-article-count-box").attachArticleMetrics) { $("#main-article-count-box").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(".new_figshare_widget"); if (figshareWidget.length > 0) { window.figshare.load("f1000", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr("figshare_articleId") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { "261570": 0, "261573": 0, "261578": 0, "261577": 0, "261583": 0, "261582": 0, "261587": 0, "261586": 0, "261585": 0, "261588": 0, "293540": 0, "276836": 0, "266980": 0, "293541": 0, "276837": 0, "266981": 0, "293542": 0, "276838": 0, "266982": 0, "293543": 0, "266983": 0, "276839": 7, "276833": 0, "266977": 0, "276834": 0, "293539": 3, "276835": 0, "266979": 0, "293548": 0, "293544": 0, "276840": 0, "266984": 0, "276841": 0, "266985": 0, "293545": 5, "293546": 0, "276842": 0, "266986": 0, "293547": 0, "266987": 0, }; $(".referee-response-container,.js-referee-report").each(function(index, el) { var reportId = $(el).attr("data-reportid"), reportCount = reportIds[reportId] || 0; $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount); }); var uuidInput = $("#article_uuid"), oldUUId = uuidInput.val(), newUUId = "08598ae6-aa7e-4f7d-8b60-61fb05e12e82"; uuidInput.val(newUUId); $("a[href*='article_uuid=']").each(function(index, el) { var newHref = $(el).attr("href").replace(oldUUId, newUUId); $(el).attr("href", newHref); }); }); An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing. Browse Gateways Collections How it Works Contact For Developers Cookie Notice Privacy Notice RSS Submit Your Research Follow us © 2012-2026 F1000 Research Ltd. ISSN 2046-1402 | Legal | Partner of Research4Life • CrossRef • ORCID • FAIRSharing R.templateTests.simpleTemplate = R.template(' $text $text $text $text $text '); R.templateTests.runTests(); var F1000platform = new F1000.Platform({ name: "f1000research", displayName: "F1000Research", hostName: "f1000research.com", id: "1", editorialEmail: "[email protected]", infoEmail: "[email protected]", usePmcStats: true }); $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');}); // $(function(){R.ui.dropdowns('.dropdown-for-referees');}); $(document).ready(function () { if ($(".cookie-warning").is(":visible")) { $(".sticky").css("margin-bottom", "35px"); $(".devices").addClass("devices-and-cookie-warning"); } $(".cookie-warning .close-button").click(function (e) { $(".devices").removeClass("devices-and-cookie-warning"); $(".sticky").css("margin-bottom", "0"); }); $("#tweeter-feed .tweet-message").each(function (i, message) { var self = $(message); self.html(linkify(self.html())); }); $(".partner").on("mouseenter mouseleave", function() { $(this).find(".gray-scale, .colour").toggleClass("is-hidden"); }); }); Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $("a[id=googleSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("GOOGLE"); $("form[id=oAuthForm]").submit(); }); $("a[id=facebookSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("FACEBOOK"); $("form[id=oAuthForm]").submit(); }); $("a[id=orcidSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("ORCID"); $("form[id=oAuthForm]").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($("#sign-in-form-gfb-popup")); $(".target-field").each(function () { var uris = $(this).val().split("/"); if (uris.pop() === "login") { $(this).val(uris.toString().replace(",","/")); } }); });